Intrexon Corp (XON)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Intrexon Corp (XON) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8010904
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月21日
◆ページ数:44
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Intrexon Corp (Intrexon), formerly Genomatix Corp is a provider of therapeutic solutions. The company operates through its divisions such as human therapeutics, protein production, industrial products, agricultural biotech, and animal sciences. Its human therapeutics division develops therapeutic product candidates for lysosomal storage diseases, hematological disorders, metabolic diseases, infectious diseases, and autoimmune disorders. Intrexon’s UltraVector platform produces and optimizes custom, complex gene systems; mAbLogix platform enables production of B-cell libraries for discovery of antibodies. The company offers RheoSwitch therapeutic system for inducible expression of single and multi-gene systems through an activator ligand. It has partnership with the channel of network collaborators and joint ventures to commercialize its technologies. Intrexon is headquartered in Germantown, Maryland, the US.

Intrexon Corp (XON) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Intrexon Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Intrexon Corp, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Intrexon Corp, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Intrexon Corp, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Intrexon Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Intrexon Corp, Medical Equipment, Deal Details 10
Venture Financing 10
Intrexon Secures US$1.1 Million In Venture Financing 10
Immunologix Raises US$0.25 Million In Venture Financing 11
Intrexon Raises US$100 Million In Series E Financing 12
Partnerships 13
OvaScience And Intrexon Enter Into Agreement For Infertility Treatments 13
Halozyme Therapeutics Enters Into Licensing Agreement With Intrexon 15
Equity Offering 16
Intrexon to Raise USD100 Million in Private Placement of Preferred Shares 16
Acquisition 17
Intrexon to Acquire GenVec 17
EKF Diagnostics Acquires 360 Genomics, Cancer Diagnostics Company, For Up To US$14.4 Million 19
Intrexon Corp – Key Competitors 21
Intrexon Corp – Key Employees 22
Intrexon Corp – Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Joint Venture 24
Recent Developments 25
Strategy And Business Planning 25
Mar 10, 2017: Intrexon Creates Precigen and Accelerates Strategic Review of Structural Options Related to Health Assets 25
Financial Announcements 26
Nov 09, 2017: Intrexon Announces Third Quarter 2017 Financial Results 26
Aug 09, 2017: Intrexon Announces Second Quarter and First Half 2017 Financial Results 29
May 10, 2017: Intrexon Announces First Quarter 2017 Financial Results 31
Mar 01, 2017: Intrexon Announces Fourth Quarter and Full Year 2016 Financial Results 33
Nov 09, 2016: Intrexon Announces Third Quarter 2016 Financial Results 36
Corporate Communications 39
Nov 27, 2017: Intrexon Announces Key Management Appointments 39
Jun 29, 2017: Intrexon Appoints Helen Sabzevari, Ph.D., Senior Vice President, Human Therapeutics and Head of Research and Development of Precigen 41
May 18, 2017: Intrexon Appoints Dr. Mark Carnegie-Brown as CEO of Oxitec 42
Apr 27, 2017: Intrexon Appoints Vinita Gupta, Leading Pharma Executive, to its Board of Directors 43
Appendix 44
Methodology 44
About GlobalData 44
Contact Us 44
Disclaimer 44

List of Tables
Intrexon Corp, Medical Equipment, Key Facts, 2016 2
Intrexon Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Intrexon Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Intrexon Corp, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Intrexon Corp, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Intrexon Corp, Deals By Market, 2011 to YTD 2017 8
Intrexon Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Intrexon Secures US$1.1 Million In Venture Financing 10
Immunologix Raises US$0.25 Million In Venture Financing 11
Intrexon Raises US$100 Million In Series E Financing 12
OvaScience And Intrexon Enter Into Agreement For Infertility Treatments 13
Halozyme Therapeutics Enters Into Licensing Agreement With Intrexon 15
Intrexon to Raise USD100 Million in Private Placement of Preferred Shares 16
Intrexon to Acquire GenVec 17
EKF Diagnostics Acquires 360 Genomics, Cancer Diagnostics Company, For Up To US$14.4 Million 19
Intrexon Corp, Key Competitors 21
Intrexon Corp, Key Employees 22
Intrexon Corp, Subsidiaries 23
Intrexon Corp, Joint Venture 24

★海外企業調査レポート[Intrexon Corp (XON)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • VMware, Inc.:企業の戦略・SWOT・財務分析
    VMware, Inc. - Strategy, SWOT and Corporate Finance Report Summary VMware, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Marfrig Global Foods SA:企業の戦略・SWOT・財務情報
    Marfrig Global Foods SA - Strategy, SWOT and Corporate Finance Report Summary Marfrig Global Foods SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Amil Assistencia Medica Internacional S/A:企業の戦略・SWOT・財務情報
    Amil Assistencia Medica Internacional S/A - Strategy, SWOT and Corporate Finance Report Summary Amil Assistencia Medica Internacional S/A - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • Blackthorn Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Blackthorn Therapeutics Inc (Blackthorn Therapeutics) is a clinical stage biopharmaceutical company that discovers and develops targeted treatments for neurobehavioral disorders. The company offers products such as BTRX-246040, an NOPR antagonist; and BTRX-335140, a KOR antagonist. It uses I …
  • IMPSA SA:企業の戦略的SWOT分析
    IMPSA SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Thi …
  • Provectus Biopharmaceuticals Inc (PVCT)-製薬・医療分野:企業M&A・提携分析
    Summary Provectus Biopharmaceuticals Inc (Provectus), formerly Provectus pharmaceuticals Inc is a biotechnology company that develops pharmaceuticals for oncology and dermatology indications. The company provides pipeline products such as PV-10 for recurrent melanoma, PV-10 for metastatic liver canc …
  • ToolGen Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary ToolGen Inc (ToolGen) is a genome editing company that concentrates on translating the genetic knowledge into transformative products for biomedicine and agriculture. The company creates intellectual property rights for essential tools and technologies for editing the genetic information in …
  • LG Household & Health Care Ltd:戦略・SWOT・企業財務分析
    LG Household & Health Care Ltd - Strategy, SWOT and Corporate Finance Report Summary LG Household & Health Care Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Smithfield Foods Inc:企業のM&A・事業提携・投資動向
    Smithfield Foods Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Smithfield Foods Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • RussNeft Oil Co (RNFT):石油・ガス:M&Aディール及び事業提携情報
    Summary RussNeft Oil Company (RussNeft) is an oil and gas company that produces, refines and distributes crude oil, gas and petroleum products. The company operates through its business divisions such as geologic exploration and reserves, production, marketing, research center, transport and gas pro …
  • Agriterra Ltd (AGTA):企業の財務・戦略的SWOT分析
    Summary Agriterra Ltd (Agriterra) is a provider of agricultural investment and sustainable development solutions. The company provide products such as beef, maize, cocoa and palm oil. It offers business in the fields of beef that conducts cattle ranching, feedlot, abattoir operations and retail unit …
  • Bank of Cyprus Public Company Ltd:企業のM&A・事業提携・投資動向
    Bank of Cyprus Public Company Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Bank of Cyprus Public Company Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mer …
  • DiaSorin SpA (DIA):企業の財務・戦略的SWOT分析
    DiaSorin SpA (DIA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Atrium Health:企業の戦略的SWOT分析
    Atrium Health - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Depomed, Inc.:企業の戦略・SWOT・財務情報
    Depomed, Inc. - Strategy, SWOT and Corporate Finance Report Summary Depomed, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • KUKA AG (KU2):企業の財務・戦略的SWOT分析
    KUKA AG (KU2) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • National Comprehensive Cancer Network-製薬・医療分野:企業M&A・提携分析
    Summary National Comprehensive Cancer Network (NCCN) is a contract research organization that offers clinical services. The organization offers research and medical information to help patients and health professionals related to cancer care. It provides subscriptions and products which include NCCN …
  • Taiheiyo Cement Corporation
    Taiheiyo Cement Corporation - Strategy, SWOT and Corporate Finance Report Summary Taiheiyo Cement Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Catabasis Pharmaceuticals Inc (CATB):企業の財務・戦略的SWOT分析
    Summary Catabasis Pharmaceuticals Inc (Catabasis Pharmaceuticals) is a clinical-stage biopharmaceutical company that discovers, develops and commercializes medicines for the treatment of multiple diseases. The company develops its product candidates using its proprietary safely metabolized and ratio …
  • Time Dotcom Berhad (TIMECOM):企業の財務・戦略的SWOT分析
    Time Dotcom Berhad (TIMECOM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆